Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib.

about

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer Pazopanib for Non-small Cell Lung Cancer: The First Case Report in Korea.Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.

P2860

Q27011840-6FA1FE46-87FD-404B-BB33-5F92D7E952F3 Q36482433-720AA34A-5665-446F-A219-DA8DCE5503A4 Q38110796-C770CBFD-A1B4-4B08-94D3-A0459FDA5F79

P2860

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib.

Item

http://www.wikidata.org/entity/Q53354363

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@en

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@nl

type

Item

label

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@en

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@nl

prefLabel

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@en

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@nl

P1476

Phase Ib trial of the oral ang ...... d concurrently with erlotinib.

@en

P2093

A Benjamin Suttle

http://www.w3.org/2001/XMLSchema#string

Alex A Adjei

http://www.w3.org/2001/XMLSchema#string

Anne Huff

http://www.w3.org/2001/XMLSchema#string

Grace K Dy

http://www.w3.org/2001/XMLSchema#string

Howard A Burris

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Infante

http://www.w3.org/2001/XMLSchema#string

Lone H Ottesen

http://www.w3.org/2001/XMLSchema#string

Qiong Wang

http://www.w3.org/2001/XMLSchema#string

S Gail Eckhardt

http://www.w3.org/2001/XMLSchema#string

Silvia Novello

http://www.w3.org/2001/XMLSchema#string

P2860

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.

Metabolism considerations for kinase inhibitors in cancer treatment

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer.

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

P2888

s10637-012-9887-6

P304

891-899

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-012-9887-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233333036

http://www.w3.org/2001/XMLSchema#string

P698

23135778

http://www.w3.org/2001/XMLSchema#string

P921

pazopanib

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib.

about

P2860

P2860

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921